Sleep Aids - Switzerland

  • Switzerland
  • Revenue in the Sleep Aids market amounts to US$52.47m in 2024. The market is expected to grow annually by 7.86% (CAGR 2024-2029).
  • In global comparison, most revenue is generated in the United States (US$2,103m in 2024).
  • In relation to total population figures, per person revenues of US$5.93 are generated in 2024.

Key regions: Thailand, Indonesia, United States, Europe, Philippines

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids market in Switzerland has been experiencing significant growth in recent years.

Customer preferences:
Swiss consumers are increasingly prioritizing their sleep quality and are actively seeking solutions to improve their sleep patterns. This is driven by a growing awareness of the importance of sleep for overall health and well-being. Additionally, the high-stress levels and demanding work schedules in Switzerland have contributed to a rise in sleep disorders, leading to a greater demand for sleep aids.

Trends in the market:
One of the key trends in the Sleep Aids market in Switzerland is the growing popularity of natural and herbal sleep aids. Swiss consumers are becoming more conscious about the ingredients they consume and are opting for products that are perceived as safer and more sustainable. As a result, there has been a shift towards natural sleep aids that contain ingredients such as valerian root, chamomile, and lavender. Another trend in the market is the increasing availability and variety of sleep aids in different formats. Swiss consumers have a wide range of options to choose from, including sleep sprays, capsules, teas, and wearable devices. This allows individuals to select the format that best suits their preferences and lifestyle.

Local special circumstances:
Switzerland is known for its high standards of quality and precision, and this extends to the Sleep Aids market as well. Swiss consumers have a preference for products that are manufactured locally or in neighboring European countries, as they believe these products adhere to strict quality standards. This has led to the growth of domestic and regional sleep aid brands in the market.

Underlying macroeconomic factors:
The strong economy and high disposable income levels in Switzerland have contributed to the growth of the Sleep Aids market. Swiss consumers are willing to invest in products that can improve their sleep quality and overall well-being. Additionally, the aging population in Switzerland has also played a role in the market growth, as older individuals are more likely to experience sleep-related issues and seek sleep aids. In conclusion, the Sleep Aids market in Switzerland is experiencing growth due to the increasing focus on sleep quality, the popularity of natural and herbal sleep aids, the availability of different formats, the preference for locally produced products, and the strong economy. As the awareness of the importance of sleep continues to grow, it is expected that the market will continue to expand in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)